Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians’ Interpretation of a US Food and Drug Administration Workshop

The US Food and Drug Administration convened a workshop to discuss clinical trial design challenges and considerations related to the treatment of nontuberculous mycobacterial pulmonary disease, to include topics such as clinical trial end points, duration, and populations. The clinicians participat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chest
Main Authors: Flume, Patrick A., Griffith, David E., Chalmers, James D., Daley, Charles L., Olivier, Kenneth, O’Donnell, Anne, Aksamit, Timothy, Kasperbauer, Shannon, Leitman, Amy, Winthrop, Kevin L.
Formato: Artigo
Idioma:Inglês
Publicado em: American College of Chest Physicians 2021
Assuntos:
Chest Infections: Special Features
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039007/
https://ncbi.nlm.nih.gov/pubmed/32853648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2020.08.2055
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados